Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

There are an increasing number of treatments available for multiple sclerosis (MS). The early identification of optimal responders to individual treatments is important to achieve individualized therapy. With this aim, we performed a multicenter retrospective longitudinal study including 186 MS pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Dominguez-Mozo, Maria Inmaculada, Perez-Perez, Silvia, Villar, Luisa María, Oliver-Martos, Begoña, Villarrubia, Noelia, Matesanz, Fuencisla, Costa-Frossard, Lucienne, Pinto-Medel, María Jesús, García-Sánchez, María Isabel, Ortega-Madueño, Isabel, Lopez-Lozano, Lorena, Garcia-Martinez, Angel, Izquierdo, Guillermo, Fernández, Óscar, Álvarez-Cermeño, Jose Carlos, Arroyo, Rafael, Alvarez-Lafuente, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455689/
https://ncbi.nlm.nih.gov/pubmed/32859922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-71283-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados